Canine parvovirus (strain 154) not less than 107.0 TCID50

Solvent (1ml per vial):
Phosphate buffered saline.

Target Species

Dogs.

Indications for use, specifying the target species

For active immunisation of dogs to prevent clinical signs of disease and excretion of virulent canine parvovirus caused by canine parvovirus infection. Onset of immunity has been shown to occur from 1 week after dosing and last for up to 3 years.

View Product Information